Medical Condition

mild traumatic brain injury

Total Trials

10

Recruiting Now

10

Trial Phases

Phase 2

ClinicalMetric tracks all active clinical trials for mild traumatic brain injury sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — mild traumatic brain injury Clinical Trials

How many clinical trials are currently recruiting for mild traumatic brain injury?

ClinicalMetric currently tracks 10 actively recruiting clinical trials for mild traumatic brain injury, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for mild traumatic brain injury?

mild traumatic brain injury research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a mild traumatic brain injury clinical trial?

Eligibility criteria for mild traumatic brain injury trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Seattle Children's Hospital

View Trial →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

mild traumatic brain injury

Frequently Asked Questions — mild traumatic brain injury Clinical Trials

Recruiting Clinical Trials

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline

Auditory Plasticity Training

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Treatment Optimization of Brain-injured Warfighters

Effect of Graded Aerobic Exercise in Mild Traumatic Brain Injury

SSVEP Evaluation of Brain Function (PRO)

Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury

Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)

REhabilitation of MEMory Symptoms After BRain Concussion

Concussion Recovery and Support Program